We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Innovative Mesh Treats Aneurysms Inside the Brain

By HospiMedica International staff writers
Posted on 15 Jun 2021
Print article
Image: The Contour Neurovascular System (Photo courtesy of Cerus Endovascular)
Image: The Contour Neurovascular System (Photo courtesy of Cerus Endovascular)
A braided implant could provide an effective, minimally invasive treatment option for life threatening bifurcated intracranial aneurysms.

The Cerus Endovascular (Oxford, United Kingdom) Contour Neurovascular System is composed of a pre-shaped fine mesh braided implant with shape memory properties and a micro-catheter delivery system. The implant, which combines a flow diverter and a flow disruptor, is designed to target the neck of an intracranial aneurysm (within the aneurysm sac itself), away from the vulnerable dome. The enhanced safety profile allows it to be used to treat a range of aneurysm morphologies and sizes, including unruptured wide-necked bifurcations.

Additional features include self-anchoring; support of neo-intimal growth across the mesh and subsequent thrombosis of aneurysm; deployment with existing endovascular clinical techniques; electrolytic detachment; no intra-arterial stabilizing component; a reduction (or even elimination) of dual anti-platelet therapy; and straightforward sizing, as the Contour does not aim for bulk replacement of the aneurysmal cavity, but only targets the neck area. The Contour Neurovascular System has received breakthrough device designation from the U.S. Food and Drug Administration (FDA).

“The Contour Neurovascular System delivers an important clinical option and represents a new, and potentially disruptive, standalone solution for the treatment of bifurcated saccular intracranial aneurysms,” said Dr. Stephen Griffin, President of Cerus Endovascular. “Importantly, physicians who have used the system have highlighted the benefits inherent in its unique simplicity, including a simple sizing approach of the device to the aneurysm width, ease of deliverability and controlled deployment.”

Wide-neck aneurysms are defined as having a neck greater or equal to four mm or a dome-to-neck ratio of less than two. They are often untreatable by surgical clipping, as many wide- neck aneurysms are in vessels deep within the brain that are not amendable to being treated by open brain surgery. Coiling wide neck aneurysms, on the other hand, could lead to coil protrusion and/or embolization, as it is difficult to achieve and maintain sufficiently dense coil packing of the aneurysm to permanently exclude blood flow.

Related Links:
Cerus Endovascular

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Video Laryngoscope
SH-VL1

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.